XML 65 R54.htm IDEA: XBRL DOCUMENT
v3.19.1

Geneos Therapeutics, Inc. (Details) $ in Millions | 1 Months Ended
--- | ---
Feb. 28, 2019 USD ($)
Geneos Therapeutics, Inc. |
Noncontrolling Interest [Line Items] |
Sale of stock, consideration received | $ 4.5
Geneos Therapeutics, Inc. |
Noncontrolling Interest [Line Items] |
Payments to acquire additional interest in subsidiaries | 1.2
Stock purchase agreement, commitment of additional investment | 0.8
Stock purchase agreement, commitment of additional investment upon milestone | $ 0.8
Noncontrolling interest, ownership percentage by parent | 61.00%

X
- Definition Stock Purchase Agreement, Commitment Of Additional Investment + References No definition available. + Details
Name: | ino_StockPurchaseAgreementCommitmentOfAdditionalInvestment
Namespace Prefix: | ino_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Stock Purchase Agreement, Commitment Of Additional Investment Upon Milestone + References No definition available. + Details
Name: | ino_StockPurchaseAgreementCommitmentOfAdditionalInvestmentUponMilestone
Namespace Prefix: | ino_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_MinorityInterestLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash outflow associated with the purchase of noncontrolling interest during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Cash received on stock transaction after deduction of issuance costs. + References No definition available. + Details
Name: | us-gaap_SaleOfStockConsiderationReceivedOnTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | dei_LegalEntityAxis=ino_GeneosTherapeuticsInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=ino_GeneosTherapeuticsInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |